H2Ocean Highlights Sea Salt Innovations at Cancer Research Symposium

Company showcases role of mineral-rich sea salt formulations in supporting oral health during cancer treatment

Published on Mar. 8, 2026

Got story updates? Submit your updates here. ›

H2Ocean, a company focused on sea salt-based health products, participated in the 4th International Conference on Cancer Health Disparities and 9th Annual UTRGV School of Medicine Research Symposium. The conference brought together cancer researchers, clinicians, and experts to discuss advancements in cancer prevention, reducing health disparities, and strengthening survivorship care. H2Ocean's Chief Scientific Officer, Dr. Rajiv Saini, delivered an invited lecture on the potential of sea salt-derived minerals in supporting oral health during and after cancer therapy. The company also exhibited its sea salt-based products designed to help manage side effects related to radiation and chemotherapy.

Why it matters

Oral complications, such as mucositis, xerostomia, and increased susceptibility to infections, are common side effects of cancer treatments like chemotherapy and radiation therapy. Addressing these issues is crucial for improving the quality of life for cancer patients. H2Ocean's participation in this conference highlights the company's commitment to developing evidence-based supportive care solutions that leverage the natural properties of sea salt to address these challenges.

The details

During the conference, Dr. Rajiv Saini, H2Ocean's Chief Scientific Officer, presented the biological rationale behind the use of mineral-rich sea salt formulations in supporting oral health during and after cancer therapy. He explained how key trace elements like sodium, magnesium, calcium, zinc, and potassium may help modulate inflammation, maintain epithelial integrity, balance the oral microbiome, and promote tissue recovery. H2Ocean also exhibited its sea salt-based products, including a Healing Rinse mouthwash, wound care solutions, and skin healing formulations, which are designed to help manage side effects related to radiation and chemotherapy.

  • The conference was held from February 28 to March 1, 2026.
  • H2Ocean has participated in this conference for multiple consecutive years.

The players

H2Ocean

A company focused on developing sea salt-based health products, including formulations to support oral health during cancer treatment.

Dr. Rajiv Saini

The Chief Scientific Officer of H2Ocean, who delivered an invited lecture on the role of sea salt-derived minerals in supporting oral health during and after cancer therapy.

Eddie Kolos

The Inventor and CEO of H2Ocean, who was personally present at the conference, engaging directly with oncology experts and healthcare professionals.

Dr. Subhash Chauhan

The Chair of the Department of Immunology and Microbiology and a leading cancer research scientist at the UTRGV School of Medicine, who provided opening remarks at the conference.

Dr. Ecerado Cobos

The Dean and Professor of the UTRGV School of Medicine and the Director of the Cancer Program, who provided opening remarks at the conference.

Got photos? Submit your photos here. ›

What they’re saying

“Understanding mineral biology opens meaningful translational opportunities in supportive oncology care. It was an honor to share these insights with a highly committed scientific community focused on improving the quality of life for cancer patients.”

— Dr. Rajiv Saini, Chief Scientific Officer, H2Ocean

“The scientific depth and collaborative spirit at this conference were truly impressive. Connecting directly with oncology experts reinforces our shared commitment to responsible, science driven supportive care solutions that may benefit patients during and after cancer treatment.”

— Eddie Kolos, Inventor and CEO, H2Ocean

What’s next

H2Ocean has initiated collaborative discussions with the University of Texas Rio Grande Valley to further explore the potential role of sea salt-based formulations in supportive cancer care through structured research projects. The collaboration aims to investigate the mechanistic pathways related to inflammation modulation, epithelial repair, microbial balance, and tissue recovery in patients undergoing chemotherapy and radiation therapy.

The takeaway

This conference participation highlights H2Ocean's commitment to responsible, science-driven innovation in supportive oncology care. By leveraging the natural properties of sea salt, the company is exploring ways to address the significant oral complications associated with cancer treatments and improve the quality of life for patients.